| Autor: |
Wang, P., Gullen, B., Newton, M. G., Cheng, Y.-C., Schinazi, R. F., Chu, C. K. |
| Zdroj: |
Journal of Medicinal Chemistry; August 26, 1999, Vol. 42 Issue: 17 p3390-3399, 10p |
| Abstrakt: |
Asymmetric syntheses of l-carbocyclic 2,3-didehydro-2,3-dideoxy- and 2,3-dideoxypyrimidine and purine nucleoside analogues were accomplished, and their anti-HIV and anti-HBV activities were evaluated. The key intermediate, (1S,4R)-1-benzoyloxy-4-(tert-butoxymethyl)cyclopent-2-ene (7), was prepared by benzoylation of the alcohol 2, selective deprotection of the isopropylidene group of 3, followed by thermal elimination via cyclic ortho ester or deoxygenation via cyclic thionocarbonate. The target compounds were also synthesized by thermal elimination via cyclic ortho esters from protected nucleosides. It was found that l-carbocyclic 2,3-didehydro-2,3-dideoxyadenosine (34) exhibited potent anti-HBV activity (EC50 = 0.9 μM) and moderate anti-HIV activity (EC50 = 2.4 μM) in vitro without cytotoxicity up to 100 μM. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
